Korro Bio (KRRO) Current Assets (2018 - 2026)

Korro Bio's Current Assets history runs 9 years deep, the most recent figure standing at $120.2 million for Q1 2026.

• Quarterly Current Assets fell 0.88% year-over-year to $120.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $120.2 million (down 0.88% YoY) and the FY2025 annual result came in at $82.4 million, down 37.37% from the prior year.
• Current Assets was $120.2 million for Q1 2026 at Korro Bio, up from $82.4 million in the prior quarter.
• Across five years, Current Assets topped out at $172.7 million in Q4 2023 and bottomed at $42.5 million in Q3 2023.
• A 5-year average of $108.4 million and a median of $113.4 million in 2022 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2023 — Current Assets slumped 57.92% — and 2024, when it soared 259.49%.
• Korro Bio's Current Assets stood at $57.1 million in 2022, then soared by 202.59% to $172.7 million in 2023, then dropped by 23.85% to $131.5 million in 2024, then slumped by 37.37% to $82.4 million in 2025, then jumped by 45.88% to $120.2 million in 2026.
• Business Quant data shows KRRO's Current Assets at $120.2 million in Q1 2026, $82.4 million in Q4 2025, and $98.2 million in Q3 2025.